Showing results (111-120 of 8,954) with videos related to
Sort By:
Pageof 896
Journal of Hepatology|August 27, 2019
The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implicationsJiajie Hou, Haiyan Zhang, Beicheng Sun, et al.Journal of Hepatology|September 10, 2019
IL-17A secreted from lymphatic endothelial cells promotes tumorigenesis by upregulation of PD-L1 in hepatoma stem cellsYuanyan Wei, Danfang Shi, Ziwei Liang, et al.Journal of Hepatology|September 10, 2019
TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infectionHaoliang Wang, Heng Luo, Xing Wan, et al.Journal of Hepatology|September 10, 2019
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosisGiammauro Berardi, Zenichi Morise, Carlo Sposito, et al.Journal of Hepatology|January 23, 2021
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCAJörn M Schattenberg, Albert Pares, Kris V Kowdley, et al.Journal of Hepatology|February 1, 1988
Amodiaquine-induced fulminant hepatitisJ Bernuau, D Larrey, B Campillo, et al.Journal of Hepatology|February 1, 1988
Analysis of factors predicting early seroconversion to anti-HBe in HBeAg-positive chronic hepatitis BJ M Sánchez-Tapias, J Costa, A Mas, et al.Journal of Hepatology|February 1, 1988
Calcium carbonate in cholesterol gallstonesA Ruiz de Aguiar, J A Medina Núñez, M I Lopez Domingo, et al.Journal of Hepatology|January 28, 2021
SARS-CoV-2 infection in patients with autoimmune hepatitisThomas Marjot, Gustav Buescher, Marcial Sebode, et al.Journal of Hepatology|January 30, 2021
STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathwayLaura Conde de la Rosa, Carmen Garcia-Ruiz, Carmen Vallejo, et al.Pageof 896